Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome-Reference-Cited by-同舟云学术

Selective targeting of Plasmodium falciparum Hsp90 disrupts the 26S proteasome

Published:2024-04 Issue:4 Volume:31 Page:729-742.e13
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Mansfield Christopher R.,Quan Baiyi,Chirgwin Michael E.,Eduful Benjamin,Hughes Philip F.,Neveu Gaëlle,Sylvester Kayla,Ryan Daniel H.,Kafsack Björn F.C.,Haystead Timothy A.J.,Leahy James W.,Fitzgerald Michael C.,Derbyshire Emily R.^ORCID

Funder

NIH

Publisher

Elsevier BV

Reference105 articles.

1. World Malaria Report,2022

2. Spread of Artemisinin Resistance in Plasmodium falciparum Malaria;Ashley;N. Engl. J. Med.,2014

3. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial;van der Pluijm;Lancet,2020

4. Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai–Myanmar Border (2003–2013): The Role of Parasite Genetic Factors;Phyo;Clin. Infect. Dis.,2016

5. The silent path to thousands of merozoites: the Plasmodium liver stage;Prudêncio;Nat. Rev. Microbiol.,2006

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study;Pathogens;2024-07-27

2. Advances in protease inhibition-based chemotherapy: A decade of insights from Malaria Research;Advances in Parasitology;2024